Upload Avatar (500 x 500)
Weimin Yu
Medical School
Wuhan University
Hubei
Language: English, Chinese
Bladder Cancer
Urothelial Cells
Cell Biology
Tumor Microenvironment
Immunotherapy
Hydronephrosis
Acute Injury
Pressure Perfusion
Cellular Mechanisms
Clinical Research
Areas of Focus
- Bladder urothelial cancer cell biology
- Tumor microenvironment and immunotherapy
- Mechanism of acute pressure perfusion injury in hydronephrosis
Work Experience
- 2020.6 to present - Wuhan University, Renmin Hospital, Chief Physician in Urology
- 2016.8-2017.8 - University of California, Davis Comprehensive Cancer Center, Visiting Scholar
- 2015.12-2020.6 - Wuhan University, Renmin Hospital, Associate Chief Physician in Urology
- 2014.10-2014.12 - Fukushima Medical University, Visiting Scholar in Urology
- 2012.12-2015.12 - Wuhan University, Renmin Hospital, Attending Physician in Urology
- 2011.7-2012.12 - Wuhan University, Renmin Hospital, Resident Physician in Urology
Academic Background & Achievements
- 2008.7–2011.6 Doctorate in Surgery: Wuhan University
- 2005.9–2008.6 Master's in Surgery: Wuhan University
- 2000.9–2005.6 Bachelor in Clinical Medicine: Wuhan University
- First and second prizes in Hubei Province Science and Technology Progress
- Published over 50 academic papers, including more than 30 SCI indexed papers
Publications
- Presence of a Novel Anatomical Structure May Cause Bleeding When Using the Calyx Access in Mini-Percutaneous Nephrolithotomy, Fangyou Lin, Bojun Li, Ting Rao, Yuan Ruan, Weimin Yu, Fan Cheng, Stéphane Larré, 2022
- TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-Κb, Ji Xing, Wu Chen, Kang Chen, Shaoming Zhu, Fangyou Lin, Yucheng Qi, Yunlong Zhang, Shangting Han, Ting Rao, Yuan Ruan, Sheng Zhao, Weimin Yu, Fan Cheng, 2022
- Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo, Zhou X, Zhao S, Li W, Ruan Y, Yuan R, Ning J, Jiang K, Xie J, Yao X, Li H, Li C, Rao T, Yu W, Cheng F, 2021
- Photobiomodulation With Blue Laser Inhibits Bladder Cancer Progression, Xia Y, Yu W, Cheng F, Rao T, Ruan Y, Yuan R, Ning J, Zhou X, Lin F, Zheng D, 2021
- Experience in management of emergency and severe cases of non-COVID-19 during the outbreak of COVID-19, Yu W, Ruan Y, Ning J, Cheng F, 2021
- Novel lncRNA XLOC_032768 protects against renal tubular epithelial cells apoptosis in renal ischemia–reperfusion injury by regulating FNDC3B/TGF-β1, Zhou X, Li Y, Wu C, Yu W, Cheng F, 2020
- Traditional Classification and Novel Subtyping Systems for Bladder Cancer, Zhu S, Yu W, Yang X, Wu C, Cheng F, 2020
- Novel lncRNA XLOC_032768 alleviates cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells through TNF-α, Zhou X, Jiang K, Luo H, Wu C, Yu W, Cheng F, 2020
- MiR-425 Promotes Migration and Invasion in Bladder Cancer by Targeting Dickkopf 3, Ning JZ, Yu WM, Cheng F, Rao T, Ruan Y, 2020
Awards
- 2023.12 First Prize for Technological Advancement in Hubei Province: Key Techniques and Clinical Application of Minimally Invasive Treatment for Kidney Stones
- 2017.12 Second Prize for Technological Advancement in Hubei Province: Clinical Technique Improvement Based on Hidden Penis Impact on Corpora Cavernosa Structure and Function
